Healthy Conversations with Rightway

Microplastics have been detected in the body, but does presence mean harm? This episode covers the emerging science on microplastics and their impact on human health.
Join Dr. Ted Feldman and Dr. Phoebe Stapleton as they discuss where microplastics have been found in the body, what current research suggests about potential health risks, and what this means for your everyday health decisions.

Weight loss comes down to a few key factors, and most people aren't focusing on the right ones. In this episode, Dr. Ted Feldman and Dr. Andrea Vitello break down the strategies that lead to lasting results. Discover the impact of diet, eating habits, exercise, and sleep on sustainable weight loss, and get an inside look at how doctors determine if medications are right for you.

Join Dr. Ted Feldman, Chief Medical Officer at Rightway, and Kristin Devlin, Senior VP of Pharmacy, as they unpack GLP-1 drugs — a groundbreaking class of medicines reshaping treatment for diabetes, obesity, and cardiometabolic disease.
In this episode, they explain:
How GLP-1s work and why they’re generating so much attention.
Who may benefit most from these therapies.
Practical considerations like safety, access, and adherence.
How Rightway supports members with benefit navigation, manufacturer programs, and cost-saving strategies.